EA200600297A1 - Лечение острого воспалительного состояния - Google Patents
Лечение острого воспалительного состоянияInfo
- Publication number
- EA200600297A1 EA200600297A1 EA200600297A EA200600297A EA200600297A1 EA 200600297 A1 EA200600297 A1 EA 200600297A1 EA 200600297 A EA200600297 A EA 200600297A EA 200600297 A EA200600297 A EA 200600297A EA 200600297 A1 EA200600297 A1 EA 200600297A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- acute inflammatory
- groups
- treatment
- bodies
- phosphate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G19/00—Compounds of tin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G15/00—Compounds of gallium, indium or thallium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Manufacturing & Machinery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
В этом изобретении предложен способ профилактики или лечения острого воспалительного расстройства, включающий введение пациенту эффективного количества фармацевтически приемлемых телец, несущих эффективное количество фосфатсодержащих групп, которые представлены или могут быть представлены на поверхности указанных телец, причем фосфатсодержащие группы содержат множество глицеролфосфатных групп или групп, поддающихся превращению в такие группы, для ингибирования и/или уменьшения прогрессирования острого воспалительного расстройства, причем указанные тельца имеют размер от примерно 20 нанометров (нм) до 500 микрометров (мкм).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48907103P | 2003-07-21 | 2003-07-21 | |
PCT/CA2004/001053 WO2005007169A2 (en) | 2003-07-21 | 2004-07-20 | Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200600297A1 true EA200600297A1 (ru) | 2006-08-25 |
Family
ID=34079469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600297A EA200600297A1 (ru) | 2003-07-21 | 2004-07-20 | Лечение острого воспалительного состояния |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070238708A1 (ru) |
EP (1) | EP1658086A2 (ru) |
JP (1) | JP2006528136A (ru) |
KR (1) | KR20060037369A (ru) |
CN (1) | CN1826123A (ru) |
AU (1) | AU2004257375A1 (ru) |
BR (1) | BRPI0412882A (ru) |
CA (1) | CA2533084A1 (ru) |
EA (1) | EA200600297A1 (ru) |
IL (1) | IL173068A0 (ru) |
MA (1) | MA28002A1 (ru) |
MX (1) | MXPA06000805A (ru) |
NO (1) | NO20060820L (ru) |
WO (1) | WO2005007169A2 (ru) |
ZA (1) | ZA200601458B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007131329A1 (en) * | 2006-05-12 | 2007-11-22 | Vasogen Ireland Limited | Treatment of ubiquitin-proteasome system dysfunction related disorders |
US8367643B2 (en) | 2007-03-29 | 2013-02-05 | National Jewish Health | Surfactant lipids, compositions thereof and uses thereof |
LT2437726T (lt) * | 2009-06-03 | 2018-09-10 | Sequessome Technology Holdings Limited | Kompozicijos, skirtos giliųjų audinių skausmo gydymui |
NZ598906A (en) | 2009-08-21 | 2014-08-29 | Targeted Delivery Technologies Ltd | Vesicular formulations |
GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
LT3316857T (lt) | 2015-06-30 | 2021-11-25 | Sequessome Technology Holdings Limited | Daugiafazės kompozicijos |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3346526C2 (de) * | 1983-12-22 | 1986-12-11 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen |
FR2658418B1 (fr) * | 1990-02-20 | 1994-09-02 | Synthelabo | Compositions pharmaceutiques a base de phospholipides. |
AU1751795A (en) * | 1994-03-04 | 1995-09-18 | University Of British Columbia, The | Liposome compositions and methods for the treatment of atherosclerosis |
US20020115609A1 (en) * | 1997-07-14 | 2002-08-22 | Hayat Onyuksel | Materials and methods for making improved micelle compositions |
EP1133301A1 (en) * | 1998-11-26 | 2001-09-19 | Britannia Pharmaceuticals Limited | Anti-asthmatic combinations comprising surface active phospholipids |
AU2580801A (en) * | 1999-12-14 | 2001-06-25 | Sky High, Llc | Phospholipid compositions as anti-inflammation agents |
US20020001614A1 (en) * | 2000-02-10 | 2002-01-03 | Kent Jorgensen | Lipid-based drug delivery systems containing phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof |
US20030040505A1 (en) * | 2000-03-31 | 2003-02-27 | The Regents Of The University Of California | Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditions |
CA2368656A1 (en) * | 2002-01-21 | 2003-07-21 | Vasogen Ireland Limited | Receptor-ligand pairing for anti-inflammatory response |
US20040009216A1 (en) * | 2002-04-05 | 2004-01-15 | Rodrigueza Wendi V. | Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
AU2003266884A1 (en) * | 2002-09-16 | 2004-04-30 | Vasogen Ireland Limited | Accelerating recovery from trauma |
WO2004037270A1 (en) * | 2002-10-25 | 2004-05-06 | Vasogen Ireland Limited | Cyclooxygenase regulation with pg liposomes |
DE10255106A1 (de) * | 2002-11-24 | 2004-06-09 | Novosom Ag | Liposomale Glucocorticoide |
-
2004
- 2004-07-20 CA CA002533084A patent/CA2533084A1/en not_active Abandoned
- 2004-07-20 US US10/565,360 patent/US20070238708A1/en not_active Abandoned
- 2004-07-20 BR BRPI0412882-6A patent/BRPI0412882A/pt not_active IP Right Cessation
- 2004-07-20 JP JP2006520639A patent/JP2006528136A/ja not_active Withdrawn
- 2004-07-20 EA EA200600297A patent/EA200600297A1/ru unknown
- 2004-07-20 MX MXPA06000805A patent/MXPA06000805A/es unknown
- 2004-07-20 AU AU2004257375A patent/AU2004257375A1/en not_active Abandoned
- 2004-07-20 EP EP04761575A patent/EP1658086A2/en not_active Withdrawn
- 2004-07-20 WO PCT/CA2004/001053 patent/WO2005007169A2/en active Application Filing
- 2004-07-20 KR KR1020067001122A patent/KR20060037369A/ko not_active Application Discontinuation
- 2004-07-20 ZA ZA200601458A patent/ZA200601458B/en unknown
- 2004-07-20 CN CNA2004800212870A patent/CN1826123A/zh active Pending
-
2006
- 2006-01-10 IL IL173068A patent/IL173068A0/en unknown
- 2006-02-20 NO NO20060820A patent/NO20060820L/no not_active Application Discontinuation
- 2006-02-20 MA MA28824A patent/MA28002A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CN1826123A (zh) | 2006-08-30 |
AU2004257375A1 (en) | 2005-01-27 |
MA28002A1 (fr) | 2006-07-03 |
MXPA06000805A (es) | 2006-04-18 |
JP2006528136A (ja) | 2006-12-14 |
US20070238708A1 (en) | 2007-10-11 |
EP1658086A2 (en) | 2006-05-24 |
ZA200601458B (en) | 2007-05-30 |
IL173068A0 (en) | 2006-06-11 |
WO2005007169A2 (en) | 2005-01-27 |
KR20060037369A (ko) | 2006-05-03 |
CA2533084A1 (en) | 2005-01-27 |
WO2005007169A3 (en) | 2005-09-22 |
NO20060820L (no) | 2006-04-10 |
BRPI0412882A (pt) | 2006-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0518228B8 (pt) | inibidores de cinesina mitótica e uso dos mesmos | |
BRPI0407375A (pt) | Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos | |
MA28102A1 (fr) | Formulations pharmaceutiques, methodes et schemas d'administration pour le traitement et la prevention des syndromes coronariens aigus | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
CY1110230T1 (el) | Αναστολεις γυρασης και χρησεις αυτων | |
CY1108706T1 (el) | Ανοσορυθμιστης | |
DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
WO2004064716A3 (en) | Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
WO2006116626A3 (en) | Methods and compositions for treating pain | |
DE60042215D1 (de) | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit | |
NO20043548L (no) | Anvendelse av flerumettede katoner for behandling av psoriasis | |
DE60313004D1 (de) | Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination | |
PE20211065A1 (es) | Metodo para tratar la epilepsia | |
EA200201276A1 (ru) | Производные арилметиламина для использования в качестве ингибиторов триптазы | |
WO2022173888A8 (en) | Pharmaceutically acceptable salts of psilocin and uses thereof | |
EA200600297A1 (ru) | Лечение острого воспалительного состояния | |
WO2007120485A3 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
BR0201862A (pt) | Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos | |
DK1082131T3 (da) | Immunoregulator | |
WO2002039994A3 (en) | Methods for the treatment and prevention of urinary stone disease | |
EA200800092A1 (ru) | Композиции в виде наночастиц и с контролируемым высвобождением, включающие арил-гетероциклические соединения | |
ATE293973T1 (de) | Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria | |
WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
ATE410172T1 (de) | Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes |